{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:11:12Z","timestamp":1783923072762,"version":"3.55.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recurrent, gestation-limited severe abdominal colic without a conventional diagnosis is rarely described. Endocrine-disrupting chemicals (EDCs) have been associated with adverse reproductive outcomes, but their relevance to recurrent pregnancy-specific gastrointestinal syndromes remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 35-year-old Chinese woman had five prior pregnancies; four were terminated because of recurrent severe lower abdominal colic, constipation, inability to maintain oral intake, and marked weight loss. Symptoms reproducibly began at 11\u201312 gestational weeks and resolved within 1\u20132 weeks after pregnancy termination. Extensive obstetric, gastrointestinal, vascular, autoimmune, genetic, and imaging evaluations were unrevealing. On 14 September 2024, first-morning urine biomonitoring by ultra-performance liquid chromatography\u2013tandem mass spectrometry (UPLC\u2013MS\/MS) showed creatinine-adjusted monoethyl phthalate 2136.48 \u03bcg\/g Cr, methylparaben 233.40 \u03bcg\/g Cr, and propylparaben 53.80 \u03bcg\/g Cr, all above the laboratory upper reference limits. A multidomain preconception program addressed avoidable EDC exposure, metabolic factors, immune-vascular factors, nutritional deficits, and gut dysbiosis. Repeat first-morning urine testing on 20 July 2025, during early pregnancy and before the historical 11\u201312-week symptom window, showed the three previously elevated biomarkers below the laboratory limits. The pregnancy was complicated by hyperemesis gravidarum and transient gestational thyrotoxicosis, but the prior intractable abdominal colic did not recur, and a healthy 3.6-kg female infant was delivered vaginally at term on 14 March 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Because biomarkers were not measured during the prior symptomatic pregnancies and the intervention was multifactorial, this case cannot establish temporality or causality. It supports targeted exposure history and selective EDC biomonitoring as a clinically modifiable, hypothesis-generating clue in carefully selected patients with recurrent, unexplained, pregnancy-specific morbidity after standard evaluation has been exhausted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1875138","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:35:14Z","timestamp":1783920914000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Recurrent gestation-limited intractable abdominal colic with elevated phthalate and paraben biomarkers: a hypothesis-generating observation"],"prefix":"10.3389","volume":"13","author":[{"given":"Suling","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine, Qingdao Lianchi Women & Infants Hospital Co., Ltd.","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadan","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University International Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University International Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Guang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University International Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1097\/AOG.0000000000004449","article-title":"Reducing prenatal exposure to toxic environmental agents: ACOG committee opinion, number 832.","volume":"138","year":"2021","journal-title":"Obstet Gynecol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1210\/er.2009-0002","article-title":"Endocrine-disrupting chemicals: an endocrine society scientific statement.","volume":"30","author":"Diamanti-Kandarakis","year":"2009","journal-title":"Endocr Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1210\/er.2015-1093","article-title":"Executive summary to EDC-2: the endocrine society\u2019s second scientific statement on endocrine-disrupting chemicals.","volume":"36","author":"Gore","year":"2015","journal-title":"Endocr Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/jes.2013.69","article-title":"Personal care product use and urinary phthalate metabolite and paraben concentrations during pregnancy among women from a fertility clinic.","volume":"24","author":"Braun","year":"2014","journal-title":"J Expo Sci Environ Epidemiol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1289\/ehp.1510514","article-title":"Reducing phthalate, paraben, and phenol exposure from personal care products in adolescent girls: findings from the HERMOSA intervention study.","volume":"124","author":"Harley","year":"2016","journal-title":"Environ Health Perspect."},{"key":"B6","doi-asserted-by":"publisher","first-page":"104580","DOI":"10.1016\/j.envint.2019.02.003","article-title":"Phthalate exposure and female reproductive and developmental outcomes: a systematic review of the human epidemiological evidence.","volume":"130","author":"Radke","year":"2019","journal-title":"Environ Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"10651","DOI":"10.1021\/acs.est.5b02617","article-title":"Levels of phthalate metabolites in urine of pregnant women and risk of clinical pregnancy loss.","volume":"49","author":"Mu","year":"2015","journal-title":"Environ Sci Technol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"127013","DOI":"10.1289\/EHP12287","article-title":"Preconception phthalate exposure and women\u2019s reproductive health: pregnancy, pregnancy loss, and underlying mechanisms.","volume":"131","author":"Nobles","year":"2023","journal-title":"Environ Health Perspect."},{"key":"B9","doi-asserted-by":"publisher","first-page":"108636","DOI":"10.1016\/j.reprotox.2024.108636","article-title":"Parabens effects on female reproductive health: review of evidence from epidemiological and rodent-based studies.","volume":"128","author":"Pulcastro","year":"2024","journal-title":"Reprod Toxicol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.envint.2019.02.025","article-title":"Urinary concentrations of bisphenol A, parabens and phthalate metabolite mixtures in relation to reproductive success among women undergoing in vitro fertilization.","volume":"126","author":"M\u00ednguez-Alarc\u00f3n","year":"2019","journal-title":"Environ Int."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1097\/AOG.0000000000002456","article-title":"Practice bulletin no. 189: nausea and vomiting of pregnancy.","volume":"131","year":"2018","journal-title":"Obstet Gynecol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1210\/jcem.75.5.1430095","article-title":"The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum.","volume":"75","author":"Goodwin","year":"1992","journal-title":"J Clin Endocrinol Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41586-023-06921-9","article-title":"GDF15 linked to maternal risk of nausea and vomiting during pregnancy.","volume":"625","author":"Fejzo","year":"2024","journal-title":"Nature."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults.","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases.","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.7326\/0003-4819-142-6-200503150-00010","article-title":"Recommendations for the diagnosis and treatment of the acute porphyrias.","volume":"142","author":"Anderson","year":"2005","journal-title":"Ann Intern Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1056\/NEJMra1608634","article-title":"Porphyria.","volume":"377","author":"Bissell","year":"2017","journal-title":"N Engl J Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1808012","article-title":"Hereditary angioedema.","volume":"382","author":"Busse","year":"2020","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1111\/all.15214","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema: the 2021 revision and update.","volume":"77","author":"Maurer","year":"2022","journal-title":"Allergy."},{"key":"B20","doi-asserted-by":"publisher","first-page":"649314","DOI":"10.1155\/2014\/649314","article-title":"Measurement of urinary biomarkers of parabens, benzophenone-3, and phthalates in a Belgian population.","volume":"2014","author":"Dewalque","year":"2014","journal-title":"Biomed Res Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.envint.2018.11.012","article-title":"Variability of urinary concentrations of phthalate metabolites during pregnancy in first morning voids and pooled samples.","volume":"122","author":"Shin","year":"2019","journal-title":"Environ Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"16001","DOI":"10.1021\/acs.est.1c04140","article-title":"Variability of urinary concentrations of phenols, parabens, and triclocarban during pregnancy in first morning voids and pooled samples.","volume":"55","author":"Shin","year":"2021","journal-title":"Environ Sci Technol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1875138\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:35:15Z","timestamp":1783920915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1875138\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":22,"alternative-id":["10.3389\/fmed.2026.1875138"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1875138","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"article-number":"1875138"}}